These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9502654)

  • 1. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys.
    Williams JK; Sukhova GK; Herrington DM; Libby P
    J Am Coll Cardiol; 1998 Mar; 31(3):684-91. PubMed ID: 9502654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
    Kitamoto S; Nakano K; Hirouchi Y; Kohjimoto Y; Kitajima S; Usui M; Inoue S; Egashira K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1522-8. PubMed ID: 15178560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol.
    Sukhova GK; Williams JK; Libby P
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1452-8. PubMed ID: 12231565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of atherosclerosis in female monkeys.
    Williams JK; Anthony MS; Honoré EK; Herrington DM; Morgan TM; Register TC; Clarkson TB
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):827-36. PubMed ID: 7600113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial factors impair vascular responses of coronary arteries.
    Williams JK; Vita JA; Manuck SB; Selwyn AP; Kaplan JR
    Circulation; 1991 Nov; 84(5):2146-53. PubMed ID: 1934384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early benefits of pravastatin to experimentally induced atherosclerosis.
    Silva EP; Fonseca FA; Ihara SS; Izar MC; Lopes IL; Pinto LE; Badimon JJ; Tuffik S; Paiva TB; Kasinski N; de Paola AV; Carvalho AC
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):389-95. PubMed ID: 11862118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen modulates responses of atherosclerotic coronary arteries.
    Williams JK; Adams MR; Klopfenstein HS
    Circulation; 1990 May; 81(5):1680-7. PubMed ID: 2331772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting effects of conjugated estrogens and tamoxifen on dilator responses of atherosclerotic epicardial coronary arteries in nonhuman primates.
    Williams JK; Honoré EK; Adams MR
    Circulation; 1997 Sep; 96(6):1970-5. PubMed ID: 9323088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries.
    Williams JK; Adams MR; Herrington DM; Clarkson TB
    J Am Coll Cardiol; 1992 Aug; 20(2):452-7. PubMed ID: 1634685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
    Mitani H; Egashira K; Kimura M
    Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
    Martínez-González J; Alfón J; Berrozpe M; Badimon L
    Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits.
    Mitani H; Egashira K; Ohashi N; Yoshikawa M; Niwa S; Nonomura K; Nakashima A; Kimura M
    Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mild endurance exercise training and pravastatin on peripheral vasodilatation of forearm resistance vessels in patients with coronary artery disease.
    Allemann Y; Vetter C; Kartal N; Eyer S; Stengel SM; Saner H; Hess OM
    Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):332-40. PubMed ID: 16079640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis.
    Williams JK; Shively CA; Clarkson TB
    Circulation; 1994 Aug; 90(2):983-7. PubMed ID: 8044971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statins have other beneficial properties besides their cholesterol lowering effect].
    Eriksson M
    Lakartidningen; 1998 Aug; 95(35):3670-2. PubMed ID: 9748780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys.
    Williams JK; Honoré EK; Washburn SA; Clarkson TB
    J Am Coll Cardiol; 1994 Dec; 24(7):1757-61. PubMed ID: 7963125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial.
    Rosenson RS; Otvos JD; Freedman DS
    Am J Cardiol; 2002 Jul; 90(2):89-94. PubMed ID: 12106834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial.
    Schwartz RG; Pearson TA; Kalaria VG; Mackin ML; Williford DJ; Awasthi A; Shah A; Rains A; Guido JJ
    J Am Coll Cardiol; 2003 Aug; 42(4):600-10. PubMed ID: 12932588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.